- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
| home:starting:usingforum:home_help_using_forums:a_a_href [06.05.2019] – [read more] sallieq | home:starting:usingforum:home_help_using_forums:a_a_href [07.10.2019] – [5 key elements of MP] sallieq | ||
|---|---|---|---|
| Line 8: | Line 8: | ||
| MP patients must: | MP patients must: | ||
| - | * take a minimum of four X 40mg doses of olmesartan (Benicar) per day | + | * take a minimum of four X 40mg doses of olmesartan (Benicar) per day (spaced evenly through the day) |
| - | + | ||
| - | * wean off any immunosuppressive or potentially immunosuppressive therapies | + | * avoid as far as possible stress and environmental immune suppression (EMF) see [[home: |
| * avoid the consumption of vitamin D, as well as certain other immunosuppressive foods; | * avoid the consumption of vitamin D, as well as certain other immunosuppressive foods; | ||
| - | * avoid as far as possible stress and environmental immune suppression (EMF) see [[home: | + | * wean off any immunosuppressive or potentially immunosuppressive therapies |
| * manage exposure to light, depending on photosensitivity and blood levels of vitamin D | * manage exposure to light, depending on photosensitivity and blood levels of vitamin D | ||
| - | The objective of the MP is to safely activate a highly versatile defense, the innate immune response. | + | **The objective of the MP is to safely activate a highly versatile defense, the innate immune response.** |
| ===== for assistance ===== | ===== for assistance ===== | ||
home/starting/usingforum/home_help_using_forums/a_a_href.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.